Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

Ítems similars

• Morbidity Results from the NSABP B-32 Trial Comparing Sentinel Lymph Node Dissection versus Axillary Dissection
  per: Ashikaga, Takamaru, et al.
  Publicat: (2010)
• Timing of Determining Axillary Lymph Node Status When Neoadjuvant Chemotherapy is Used
  per: Mamounas, Eleftherios P.
  Publicat: (2014)
• Surgeon Training, Protocol Compliance, and Technical Outcomes From Breast Cancer Sentinel Lymph Node Randomized Trial
  per: Krag, David N., et al.
  Publicat: (2009)
• Metastasis Detection in Sentinel Lymph Nodes: Comparison of a Limited Widely Spaced (NSABP protocol B-32) and a Comprehensive Narrowly Spaced Paraffin Block Sectioning Strategy
  per: Weaver, Donald L., et al.
  Publicat: (2009)
• Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer
  per: Harlow, Seth P., et al.
  Publicat: (2005)